Is reduction in the risk of vision loss the only benefit of photodynamic therapy in predominantly classic subfoveal choroidal neovascularization?

類似資料

• Effect of Photodynamic Therapy with Posterior Sub-Tenon Triamcinolone Acetonide on Predominantly Classic Choroidal Neovascularization: One-Year Results
  著者:: Sertoz, Ayzin Deniz, 等
  出版事項: (2008)
• Photodynamic therapy in non‐subfoveal choroidal neovascularization secondary to pathological myopia: 1‐year outcome
  著者:: Reche‐Frutos, Juan, 等
  出版事項: (2007)
• Indocyanine Green Angiographic Features of Myopic Subfoveal Choroidal Neovascularization as a Prognostic Factor after Photodynamic Therapy
  著者:: Byeon, Suk Ho, 等
  出版事項: (2006)
• Cost utility of photodynamic therapy for predominantly classic neovascular age related macular degeneration
  著者:: Hopley, C, 等
  出版事項: (2004)
• Verteporfin photodynamic therapy in highly myopic subfoveal choroidal neovascularisation
  著者:: Montero, J A, 等
  出版事項: (2003)